Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Ibuprofen for Children
Active Ingredient: Ibuprofen 20mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Drug Houses of Australia Private Limited, Singapore
Product: Lemsip For Pharmacy Sinus Day & Night
Day Tablet:
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
Night Tablet:
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Lemsip For Pharmacy Sinus Pain & Allergy
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Lemsip For Pharmacy Cold & Flu
Active Ingredients: Codeine phosphate hemihydrate 6mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Product: Lemsip For Pharmacy Cold & Flu Day & Night
Day Tablet:
Active Ingredients: Codeine phosphate hemihydrate 6mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
Night Tablet:
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Tablet
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand
Dated this 9th day of May 2013.
DR MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).